Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Misra, Dawn P.
1996.
The effect of the pregnancy‐induced hypertension on fetal growth: a review of the literature.
Paediatric and Perinatal Epidemiology,
Vol. 10,
Issue. 3,
p.
244.
Dammann, Olaf
Dammann, Christiane E.L.
Allred, Elizabeth N.
and
Veelken, Norbert
2001.
Fetal growth restriction is not associated with a reduced risk for bilateral spastic cerebral palsy in very-low-birthweight infants.
Early Human Development,
Vol. 64,
Issue. 2,
p.
79.
Magee, Laura A.
2001.
Antihypertensives.
Best Practice & Research Clinical Obstetrics & Gynaecology,
Vol. 15,
Issue. 6,
p.
827.
Islami, D
Shoukir, Y
Dupont, P
Campana, A
and
Bischof, P
2001.
Is cellular fibronectin a biological marker for pre-eclampsia?.
European Journal of Obstetrics & Gynecology and Reproductive Biology,
Vol. 97,
Issue. 1,
p.
40.
Magee, L.A.
von Dadelszen, P.
Bohun, C.M.
Rey, E.
El-Zibdeh, M.
Stalker, S.
Ross, S.
Hewson, S.
Logan, A.G.
Ohlsson, A.
Naeem, T.
Thornton, J.G.
Abdalla, M.
Walkinshaw, S.
Brown, M.
Davis, G.
and
Hannah, M.E.
2003.
Serious Perinatal Complications of Non-Proteinuric Hypertension: An International, Multicentre, Retrospective Cohort Study.
Journal of Obstetrics and Gynaecology Canada,
Vol. 25,
Issue. 5,
p.
372.
von Dadelszen, Peter
and
Magee, Laura A
2005.
Antihypertensive Medications in Management of Gestational Hypertension-Preeclampsia.
Clinical Obstetrics and Gynecology,
Vol. 48,
Issue. 2,
p.
441.